Introduction
This analysis examines the current position and future outlook for Altana in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-7 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
- Assess the market potential of Altana’s late stage pipeline products, Alvesco and Daxas
- Benchmark Altana’s performance against key rivals in the ethical pharmaceutical sector
- Learn why Altana should use in-licensing or acquisition to diversify its product base
Other selected research from the 'Companies' category:
Eli Lilly & Co.: PharmaVitae Profile 2006
This analysis examines the historical and forecast performance for Eli Lilly in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information. Learn More
Biotechnology: Global Industry Guide 2008
This is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. Learn More
Other selected research from the 'PharmaVitae' category:
Barr Pharmaceuticals Inc.: PharmaVitae Profile 2008
Analysis of Barr Pharmaceuticals’ corporate strategy, marketed portfolio, pipeline potential and financial position in 2007 and to 2013 Learn More
PharmaVitae 2005: King Pharmaceuticals Global Analysis
This analysis examines the current position and future outlook for King in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information. Learn More
Other selected research from the 'Companies' category:
PharmaVitae 2004: Sanofi-Aventis Global Analysis
This analysis examines the current position and future outlook for Sanofi-Aventis in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 7 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information Learn More
PharmaVitae Company Comparator Tool - Global Analysis
Datamonitor`s PharmaVitae Company Comparator Tool builds from the PharmaVitae profile series for the 50 leading pharma and biotech companies. Updated monthly, the new tool will allow you to compare the 50 players by current and forecast sales by therapy area. At a strategic level, compare companies by generic risk, R&D dependence and segment portfolios by age, value and source of products. Learn More